1. Home /
  2. Biotechnology


Where Health Meets Tech: 7 Testing and Diagnostics Stocks to Know

Experts pick their favorite long-term investments in medical diagnostics, testing and laboratory services.

Biogen Jumps on Alzheimer's Drug News, But What Do the Charts Say?

Let's take a close look at BIIB and arrive at a strategy for the shares.

Novavax and Its $1.6 Billion Award Just Got My Attention

The smallish clinical-stage vaccine company looks like a trade, not an investment, and might be approached as an option play.

Pandora's Scary Box, Apple Optimism?, Regeneron, Trading Sanofi

Markets are clearly different now. I did not grow up, nor was I trained for this environment. Nobody else you hear today was either.

Novavax Could Surprise on the Upside - No Bearish Divergences Yet

Let's review the charts and indicators.

Count Me a Covid-19 Skeptic, Including When It Comes to a Vaccine

The extent of the measures taken to combat the virus seem to be an overreaction, and no one should count on a vaccine being a magic bullet.

Pfizer's Pullback Sweetens the Pill

The drugmaker is a buying opportunity right now.

Alnylam Pharma Poised to Shoot Higher

The biopharmaceutical company shows bullish charts that signal a breakout to new all-time highs. The charts and indicators are bullish,

No Predictions, But 2 Picks for the Second Half of 2020

BioDelivery Sciences International and Tivity Health are two candidates investors should consider going forward.

Regeneron Pharmaceuticals Has Made a Major Upside Breakout

Now that REGN has clearly broken out above the highs of 2015 there is no chart resistance.